Scheduled Maintenance. MDBriefCase will be down on Sunday, November 27, 2022.
We are busy updating our website and learning platform to enhance your learning experience. We’ll be back up and running again before long, so please try again soon.

Pharmacy Leadership in Oncology –
Virtual Learning Series

The role of oncology pharmacists in the care of patients with cancer is critical given the complexities related to cost, tolerability, safety of oral oncology medications, issues of access, monitoring and follow-up of patients receiving this therapy. 

The Novartis Virtual Learning Series is designed to keep oncology pharmacists informed on the evolving body of knowledge in oncology and to help pharmacists implement new best processes at their clinical settings for better patient outcomes.

Video Assets

Our Virtual Library of learning resources allows pharmacists to learn at their own pace and engage with the material in a variety of formats: accredited patient case modules, expert video briefs, live and on-demand webinars.

Learning Aims

Provide the latest clinical information and resources to help oncology pharmacists to enhance the care of patients with cancer who receive oncology treatments. 

Learning Objectives

  • Boost oncology pharmacists’ leadership and knowledge in Oncology and help them implement highly specialised therapeutic area guidelines to secure best patient outcomes.
  • Provide world-class online education for oncology pharmacists
  • Drive awareness of the burden of disease, such as solid tumour cancers, haematology cancers, and showcase the value of innovative treatments in the Kingdom of Saudi Arabia.

Upcoming Webinars

MARCH
30

Webinar Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

  • Dr. Hajer Yousef Almudaiheem
  • Dr. Noura Alkhudair
  • Dr. Abdullah Alsharm

Continuing Medical Education Modules

Accredited continuing medical education modules, featuring real-world patient cases, will help pharmacists to enhance the care of patients with cancer who receive oncology treatments, as well as stay up to date on new practices and guidelines. 

Straight Talk on COVID-19 Series

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

 

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

MARCH
30

5:00 PM – 8:00 PM

Expert Brief Videos

In this expert brief video series, recognized opinion leaders present and discuss new scientific information, latest clinical data and trials. The briefs can be watched at any convenient time and on any device, ensuring that continuing medical education fits the schedule of a busy healthcare professional. 

This program series is accredited by the Saudi Commission for Health Specialities (SCFHS).

This program is supported by Novartis.